Body Composition, Fitness, and Thermoregulation in Young Boys With Type I Diabetes vs. Healthy Soccer Players
BCFTYR
Assessment of Differences in Body Composition, Physical Fitness, and Thermoregulatory Response to Incremental Exercise in Young Boys With Type I Diabetes and Healthy Soccer Players
1 other identifier
interventional
40
1 country
1
Brief Summary
The study aims to assess differences in body composition, exercise capacity, and thermoregulation between young soccer players with type 1 diabetes and their healthy peers. Real-time glycemic monitoring during exercise will provide insights for developing effective diabetes management strategies, enhancing athletes' health and performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Start
First participant enrolled
February 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 26, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
February 25, 2026
February 1, 2026
6 months
October 20, 2024
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Skin temperature changes
Thermal images of the lower limbs will be taken using a thermal camera (Flir SC 640, manufactured in the USA) before, during, and after exercise (during recovery). The assessment will be performed in degrees Celsius (°C).
during the test
Core temperature changes
Core temperature will be measured using the eCelsius Performance system (BodyCap, France).
Core temperature recording will start 12 hours before the exercise test and continue throughout its duration.
Secondary Outcomes (1)
Glycemic monitoring
during the test
Other Outcomes (11)
Antropometric measurement - weight
before test
Antropometric measurement - height
before test
Bone Mineral Density (BMD):
before test
- +8 more other outcomes
Study Arms (2)
Diabetes
EXPERIMENTALThe study group will consist exclusively of diabetics and they will undergo the described treadmill stress test to exhaustion.
Control
ACTIVE COMPARATORThe control group will consist exclusively of healthy participants and they will undergo the described treadmill stress test to exhaustion (identical to the study group).
Interventions
A graded exercise test will be performed on a treadmill. After 3 minutes of standing on the treadmill, participants will walk at a speed of 4 km/h for the first 3 minutes, then the speed will be increased to 8 km/h. After this point, the treadmill speed will be increased by 2 km/h every 3 minutes until voluntary exhaustion.
Eligibility Criteria
You may qualify if:
- Active soccer training for at least 5 years
You may not qualify if:
- Comorbidities significantly affecting metabolism and thermoregulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Paweł Kormanlead
Study Sites (1)
Human Movement Analysis Laboratory LaBthletics Academy of Physical Education in Poznań
Poznan, Wlkp, 61-871, Poland
Related Publications (5)
Wierzbicka E, Swiercz A, Pludowski P, Jaworski M, Szalecki M. Skeletal Status, Body Composition, and Glycaemic Control in Adolescents with Type 1 Diabetes Mellitus. J Diabetes Res. 2018 Sep 3;2018:8121634. doi: 10.1155/2018/8121634. eCollection 2018.
PMID: 30250851BACKGROUNDMysliwiec A, Skalska M, Michalak A, Chrzanowski J, Szmigiero-Kawko M, Lejk A, Jastrzebska J, Radziminski L, Lopez-Sanchez GF, Gawrecki A, Jastrzebski Z. Responses to Low- and High-Intensity Exercise in Adolescents with Type 1 Diabetes in Relation to Their Level of VO2 Max. Int J Environ Res Public Health. 2021 Jan 15;18(2):692. doi: 10.3390/ijerph18020692.
PMID: 33467392BACKGROUNDDe Ridder F, Ledeganck KJ, De Winter B, Braspenning R, Delbeke D, Renard E, Pozzilli P, Pieralice S, Vissers D, De Block C. Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION-1 study. Diabetes Metab Res Rev. 2022 Sep;38(6):e3537. doi: 10.1002/dmrr.3537. Epub 2022 May 21.
PMID: 35533265BACKGROUNDReddy R, Wittenberg A, Castle JR, El Youssef J, Winters-Stone K, Gillingham M, Jacobs PG. Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes. Can J Diabetes. 2019 Aug;43(6):406-414.e1. doi: 10.1016/j.jcjd.2018.08.193. Epub 2018 Aug 30.
PMID: 30414785BACKGROUNDMcGinn R, Carter MR, Barrera-Ramirez J, Sigal RJ, Flouris AD, Kenny GP. Does type 1 diabetes alter post-exercise thermoregulatory and cardiovascular function in young adults? Scand J Med Sci Sports. 2015 Oct;25(5):e504-14. doi: 10.1111/sms.12344. Epub 2014 Dec 8.
PMID: 25487370BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anna Straburzynska-Lupa, Prof
Department of Physical Therapy and Sports Recover, Poznan University of Physical Education
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
October 20, 2024
First Posted
November 6, 2024
Study Start
February 15, 2026
Primary Completion (Estimated)
August 26, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- 09.2025 - 07.2027
- Access Criteria
- Access to Individual Participant Data (IPD) is granted to researchers affiliated with recognized academic or healthcare institutions for legitimate scientific research purposes.
All IPD will be disclosed except for information that allows for the personal identification of study participants.